v3.23.1
Condensed Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Operating expenses:    
Research and development $ 1,338 $ 1,289
General and administrative 1,923 1,716
Total operating expenses 3,261 3,005
Loss from operations (3,261) (3,005)
Interest income, net 4 1
Other income, net 1
Total other income, net 4 2
Net loss $ (3,257) $ (3,003)
Net loss per share, basic and diluted $ (0.36) $ (0.33)
Weighted-average shares of common stock outstanding, basic and diluted 9,089,989 8,992,404

Source